dx29 is an AI-assisted platform developed by Foundation29 to support the diagnosis of rare genetic diseases, addressing the lengthy average diagnosis time of 5 years. The platform utilizes next-generation genetic sequencing data and natural language processing to assist physicians in navigating complex diagnostic pathways. Currently in beta, dx29 is designed to be a free, cloud-based resource that fosters collaboration and innovation in the diagnosis of rare diseases.